0001144204-11-056641.txt : 20111005
0001144204-11-056641.hdr.sgml : 20111005
20111005215641
ACCESSION NUMBER: 0001144204-11-056641
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110927
FILED AS OF DATE: 20111005
DATE AS OF CHANGE: 20111005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bronfeld Zeev
CENTRAL INDEX KEY: 0001298522
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50298
FILM NUMBER: 111128189
MAIL ADDRESS:
STREET 1: 6 URI STREET
CITY: TEL AVIV
STATE: L3
ZIP: 64954
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001176309
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980376008
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0831
BUSINESS ADDRESS:
STREET 1: 2 ELZA STREET
CITY: JERUSALEM
STATE: L3
ZIP: 93706
BUSINESS PHONE: 011 972-54-7909058
MAIL ADDRESS:
STREET 1: 2 ELZA STREET
CITY: JERUSALEM
STATE: L3
ZIP: 93706
FORMER COMPANY:
FORMER CONFORMED NAME: Integrated Security Technologies, Inc.
DATE OF NAME CHANGE: 20040614
FORMER COMPANY:
FORMER CONFORMED NAME: IGUANA VENTURES LTD
DATE OF NAME CHANGE: 20020625
4/A
1
v236639_4a.xml
OWNERSHIP DOCUMENT
X0304
4/A
2011-09-27
2011-09-28
1
0001176309
ORAMED PHARMACEUTICALS INC.
ORMP.OB
0001298522
Bronfeld Zeev
6 URI STREET
TEL AVIV
L3
64954
ISRAEL
0
0
1
0
Common Stock
2011-09-27
4
S
0
350000
0.28
D
5808517
D
Common Stock
781250
I
Via DNA Biomedical Solutions Ltd.
D.N.A Biomedical Solutions Ltd. ("DNA") owns 781,250 shares of common stock of the Issuer ("Common Stock") and warrants exercisable for 273,438 shares of Common Stock. The Reporting Person holds 22.13% of DNA's outstanding share capital. The Reporting Person and Mr. Meni Mor are parties to a Voting Agreement relating to their shares of DNA, representing, in the aggregate, approximately 44.36% of DNA's outstanding share capital. As a result of the Voting Agreement, the Reporting Person may be deemed a beneficial owner of, and to share the power to vote and dispose, the Issuer securities held by DNA. The Reporting Person disclaims beneficial ownership of any of the Issuer securities held by DNA. The Form 4 is being amended to correct the percentages of DNA outstanding share capital owed by the Reporting Person and Mr. Mor referenced in this footnote.
The Form 4 is also being amended to check the exit box is indicating that the Reporting Person is no longer subject to Section 16.
/s/ Zeev Bronfeld
2011-10-05